Company Overview and News

Earnings of SBS Philippines plunge 90%

2018-04-03 bworldonline
SBS Philippines Corp. reported a 90% drop in earnings in 2017 due to the absence of one-time gains and higher expenses to support its diversification program.
Upvote Downvote

PSE underperforms regional marts

The local stock barometer slipped back to the 8,300 level in thin trading on Thursday, underperforming regional markets, as foreign investors continued to trim holdings while local investors traded mostly volatile smaller-cap stocks.
Upvote Downvote

SBS completes acquisition of P520-million warehouse

2018-02-12 bworldonline
SBS PHILIPPINES Corp. has completed its P520-million acquisition of a warehouse facility owned by the local unit of multinational beverage giant The Coca-Cola Corp.
Upvote Downvote

No change in PSE index; sectors undergo revamp

2018-02-12 bworldonline
THE 30-MEMBER Philippine Stock Exchange index (PSEi) will remain unchanged, according to the bourse’s latest review covering full year 2017.
Upvote Downvote

PSEi remains sluggish

The local stock barometer slipped on Monday as investors remained cautious following the recent global market turbulence.
Upvote Downvote

SBS injects more capital into subsidiary LHC

2018-01-29 bworldonline
SBS PHILIPPINES Corp. is infusing more capital into its subsidiary to fund the acquisition of warehouse facility owned by a subsidiary of multinational beverage giant The Coca-Cola Corp.
Upvote Downvote

SBS buys Coca-Cola warehouse property in Laguna for P520 M

2018-01-03 philstar
MANILA, Philippines — Listed chemical firm SBS Philippines Corp. continues with its property buying spree as it is set to acquire Coca-Cola warehouse facilities and property in Laguna for P520 million. 
Upvote Downvote

SBS Philippines buys Coca-Cola’s warehouse

2018-01-03 bworldonline
SBS PHILIPPINES Corp. is taking over a warehouse facility owned by a subsidiary of multinational beverage giant The Coca-Cola Corp. to improve its distribution capability and generate gains from operational enhancements and diversification of income streams.
Upvote Downvote

SBS buys Coca-Cola’s Calamba industrial lot

SBS Philippines Corp., a chemical trading firm which is diversifying into the property business, has signed a deal to acquire a five-hectare property with warehousing facilities used by beverage giant Coca-Cola in Calamba, Laguna for P520 million.
Upvote Downvote

SBS completes stock rights offer

2017-12-13 philstar
The company offered 302 million shares to existing stockholders as of Nov. 22, 2017 at the proportion one common share for every 4.1325 common shares at a  price of P4.67 per rights share.
Upvote Downvote

SBS creates new unit for warehouse investment

2017-11-21 bworldonline
SBS PHILIPPINES Corp. has formed a new unit that will handle its planned investment in a warehouse facility, as part of the company’s efforts to ramp up its property portfolio.
Upvote Downvote

SBS Philippines receives PSE approval for stock rights offer

2017-11-02 bworldonline
SBS Philippines Corp. has secured approval from the Philippine Stock Exchange to proceed with its stock rights offering.
Upvote Downvote

SBS Holdings expands land bank

2017-10-26 philstar
MANILA, Philippines — SBS Holdings and Enterprises Corp. (SHEC), a wholly owned subsidiary of listed chemicals company SBS Philippines Corp., continues to strengthen its property business through the acquisition of more land.
Upvote Downvote

SHEC buys HK-based firm

2017-10-19 bworldonline
SBS PHILIPPINES Corp. is taking its expansion overseas with the acquisition of a company with property interests in Hong Kong for P77 million.
Upvote Downvote

SBS Philippines widens land bank

2017-10-03 philstar
MANILA, Philippines — SBS Philippines Corp. has signed an agreement to acquire a prime property in Mandaluyong City.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...